Search Results - "YOSHIDA, Barbara A"

A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen by Schietinger, Andrea, Philip, Mary, Yoshida, Barbara A., Azadi, Parastoo, Liu, Hui, Meredith, Stephen C., Schreiber, Hans

“…Monoclonal antibodies have become important therapeutic agents against certain cancers. Many tumor-specific antigens are mutant proteins that are predominantly…”
Get full text

Physical and Functional Interaction of Androgen Receptor with Calmodulin in Prostate Cancer Cells by Cifuentes, Eugenia, Mataraza, Jennifer M., Yoshida, Barbara A., Menon, Mani, Sacks, David B., Barrack, Evelyn R., Reddy, G. Prem-Veer

“…Ca2+and calmodulin (CaM) play a critical role in proliferation and viability of a wide variety of cells, including prostate cancer cells. We examined two…”
Get full text

Mitogen-activated protein kinase kinase 4/stress-activated protein/erk kinase 1 (MKK4/SEK1), a prostate Cancer metastasis suppressor gene encoded by human chromosome 17 by YOSHIDA, B. A, DUBAUSKAS, Z, CHEKMAREVA, M. A, CHRISTIANO, T. R, STADLER, W. M, RINKER-SCHAEFFER, C. W

“…The introduction of a discontinuous approximately 70-cM portion of human chromosome 17 significantly suppresses the metastatic ability of AT6.1 rat prostate…”
Get full text

Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers by KIM, Hyung L, VANDER GRIEND, Donald J, KARRISON, Theodore, LIN, Anning, STADLER, Walter M, ICHIKAWA, Tomo, RUBIN, Mark A, RINKER-SCHAEFFER, Carrie W, XIMING YANG, BENSON, David A, DUBAUSKAS, Zita, YOSHIDA, Barbara A, CHEKMAREVA, Marina A, ICHIKAWA, Yayoi, SOKOLOFF, Mitchell H, ZHAN, Ping

“…We have shown recently (B. A. Yoshida et al., Cancer Res., 59: 5483-5487) that mitogen-activated protein kinase kinase 4 (MKK4) can suppress AT6.1 rat prostate…”
Get full text

Metastasis-Suppressor Genes: a Review and Perspective on an Emerging Field by Yoshida, Barbara A., Sokoloff, Mitchell M., Welch, Danny R., Rinker-Schaeffer, Carrie W.

“…Metastasis is the most lethal attribute of a cancer. There is a critical need for markers that will distinguish accurately those histologic lesions and…”
Get full text

Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases by CHEKMAREVA, M. A, KADKHODAIAN, M. M, HOLLOWELL, C. M. P, HYUNG KIM, YOSHIDA, B. A, LUU, H. H, STADLER, W. M, RINKER-SCHAEFFER, C. W

“…To improve the diagnosis and treatment of cancer, an increased understanding of the molecular and cellular changes that regulate metastatic ability is…”
Get full text

Development of markers of prostate cancer metastasis: Review and perspective by Christiano, Arthur P, Yoshida, Barbara A, Dubauskas, Zita, Sokoloff, Mitchell, Rinker-Schaeffer, Carrie W

Get full text

Development of markers of prostate cancer metastasis by Christiano, Arthur P, Yoshida, Barbara A, Dubauskas, Zita, Sokoloff, Mitchell, Rinker-Schaeffer, Carrie W

Get full text

Prostate cancer metastasis-suppressor genes: a current perspective by Yoshida, B A, Chekmareva, M A, Wharam, J F, Kadkhodaian, M, Stadler, W M, Boyer, A, Watabe, K, Nelson, J B, Rinker-Schaeffer, C W

“…Prostate cancers account for 43% of all cancers diagnosed in American men. It is estimated that in 1996, 317,000 new cases of prostate cancer were diagnosed…”
Get more information